Major health deal is secured for Randox

The contract, which is one of the firm’s most financially significant to date, will see the Crumlin company supplying cutting edge laboratory equipment to the Ministry of Health.

The deal, worth at least £6 million over the next five years, will result in the delivery of 50 of Randox’s pioneering RX Daytona Plus analysers to hospitals across Saudi Arabia in 2013, with the potential for further orders next year.

The state-of-the art RX Daytona Plus is used in the analysis of blood and installation of the analysers in hospital laboratories in Saudi Arabia is already underway.

Dr Peter Fitzgerald, Managing Director at Randox said the deal with the Saudi Ministry of Health would allow for further re-investment in the rapidly expanding business:

“With the G8 summit, there is emphasis on promoting Northern Ireland as a centre of innovation, as open for business, the success of Randox in Saudi Arabia is proof of this.

“Randox technology developed in County Antrim is recognised across the globe as revolutionary; of the highest quality; helping save lives every day; the deal with the Saudi Ministry of Health is further recognition of the quality of our products.

“At Randox we commit more than a quarter of all revenue into research and development, keeping us ahead of the competition, contracts like this mean we can continue to do so.”

The Saudi Ministry of Health has also agreed to purchase Randox reagents, the chemicals used in laboratory analysis, to run on the RX Daytona Plus analysers, generating business for Randox, worth around £1 million a year.

Graeme McNeill, Global Manager for Randox RX series analysers, said: “Randox analysers are used in every corner of the globe, from the veterinary laboratories at Kruger National Park in South Africa, to the heart of research at Harvard University; adding the Saudi Ministry of Health to our extensive list of customers only strengthens our reputation.